Mid cap
ICRA lifts dividend to ₹105/share, 75% more than last year
Board recommends ₹35 special dividend atop ₹70 regular dividend, signalling confidence despite modest profit growth.
Wabag FY26 PAT up 26%, order book at ₹172 bn
Annual results in line with guidance; dividend of ₹5 per share recommended. Routine filing, no surprises.
JK Lakshmi Cement's Durg expansion gets costlier and later
Capex revised to ₹4,000 cr from ₹3,000 cr; commissioning pushed to end-FY28. Q4 EBITDA/ton slumps to ₹730 amid cost inflation.
ICRA lifts dividend to ₹105 per share, up 75%
Special dividend marks 35th anniversary; standalone profit slips 14.5% on higher costs.
MedPlus targets 800 new stores in FY27, private label margins recover
Management guides same-store sales growth of 9-10% annually and zero external debt. Private label contribution to rise 20-30 bps per quarter.
BlackBuck logs ₹160 cr PAT in first full year, warns of West Asia risk
Revenue rose 55% in FY26; management says conflict could slow trade volumes in the near term.
JSW Dulux posts record 23% volume growth in Q4, flags raw material pressure
Transcript confirms price hikes of 9.7% taken after corrective cuts; integration with JSW Paints underway.
Honasa's FY26 profit jumps 177% to ₹191 cr; maiden dividend of ₹3
Audited results confirm prior disclosures; the dividend is the stand-out new item, though the market had already absorbed the headline numbers.
Finolex Cables loses CS and Compliance Officer
Siddhesh Mandke resigns for personal reasons, effective June 11, 2026; departure is at the compliance level, not top executive.
LMW locks in ₹3,300 cr order book, execution is the test
Conference call highlights sharp order inflow and capacity utilization plans; no new guidance surprises.
Wabag meets FY26 guidance: 20% revenue growth, ₹172 bn orders
Revenue of ₹3,944 cr and PAT of ₹370 cr were in line with prior company guidance; market reaction already priced in.
Emami eyes double-digit summer growth, 30% lift in strategic bets
Management's H1 FY27 outlook sees summer brands recovering, international business stabilising, and a portfolio of newer bets targeting 30% growth.
Fine Organic cuts margin guidance, flags flat revenue till FY28
Capacity constraints until SEZ plant in H2 FY28, raw material pressures, and shift to short-term contracts push sustainable EBITDA margin down to 18-20%.
Honasa confirms strong FY26 with 177% profit surge, maiden dividend
Audited results validate already-disclosed performance; unmodified opinion adds credibility.
Happy Forgings confirms FY26 results; key moves already disclosed
Audited numbers match prior board meeting; ₹4 final dividend and solar capacity expansion to 35 MW were flagged earlier.
Happy Forgings' annual results were already known; board adds minor solar capex
Routine board meeting: results pre-disclosed, auditors reappointed. Solar plant capacity raised to 35 MW with ₹50 cr additional outlay — immaterial for a ₹11,742 cr market cap.
Honasa posts record Q4 revenue, doubles profit, declares maiden dividend
Third consecutive quarter of 20%+ growth; ₹3 per share dividend signals management confidence in cash flows.
Happy Forgings posts 30.7% PAT jump; ₹4 dividend as guided
Audited FY26 results confirm earlier board meeting disclosure. Revenue up 9.8%, PAT up 30.7% — no surprises.
Honasa PAT jumps 177% as board declares maiden dividend
FY26 revenue up 14% to ₹2,305.4 crore; Q4 PAT rises 162% to ₹64.5 crore; board recommends ₹3 per share dividend.
Sudeep Pharma FY26: Revenue up 28%, PAT at ₹174 cr
Speciality ingredients segment drives strong performance; company recommends ₹1.50 per share final dividend.
Happy Forgings' FY26 profit jumps 31% as growth remains steady
Annual numbers were largely anticipated after quarterly cues. The bigger news is a ₹50 crore solar expansion that nudges green capex to ₹170 crore.
Sudeep Pharma wraps FY26 with 28% revenue growth, 26% PAT jump
Audited annual numbers confirm strong speciality ingredients demand and NSS Ireland contribution; final dividend of ₹1.50 per share recommended.
RCF's net profit doubles to ₹429.81 cr, board declares ₹1.34 final dividend
Q4 profit jumps 160% to ₹188.63 cr on higher subsidies and gas pooling. Full-year revenue crosses ₹5,580 cr.
Galaxy Surfactants guides Q1 volume growth to upper end of 6-8% range
Management sees EBITDA per tonne between ₹19,000-21,000 for the June quarter; India grows 8%, AMET contracts 15%.
Alembic sets FY27 revenue growth target at low double digits
Q4 FY26 conference call transcript confirms guidance for low double-digit revenue growth, R&D spend of ₹750-800 crore, and margin improvement.